US-based medical device company Reverse Medical has obtained CE Mark approval for its BARREL vascular reconstruction device, intended for use with occlusive devices in the treatment of intracranial aneurysms.
The company has also announced the initial clinical use of the BARREL vascular reconstruction device for the treatment of intracranial bifurcation aneurysm in Europe.
Reverse Medical president and CEO Jeffrey Valko noted the BARREL vascular reconstruction device represents the company’s ongoing commitment as a neuro endovascular technology innovation company.
"We plan to expand our clinical experience with the BARREL technology, and begin commercialization in Europe through a network of expert distributors by mid 2014.
"The BARREL design is simple and elegant, essentially reducing the neck size of wide-neck bifurcation aneurysms, enabling traditional coil embolization, a craft already mastered by the Neuro Interventionalist," Valko added.
Fondation Rothschild Hospital Department of Interventional Neuroradiology director Dr Michel Piotin noted the first experience with the BARREL VRD in a wide-neck bifurcation intracranial aneurysm was impressive.
"The device tracked easily through tortuous anatomy, had excellent angiographic visibility, was easily and completely re-sheathable, and deployed very nicely. The device required no radial orientation maneuvers for accurate placement, providing a single device alternative to surgery, or to technically challenging ‘X-Y’ stenting for these complex bifurcation aneurysms.
"I expect the BARREL to become an important tool in our practice," Dr Piotin added.